Dublin, Jan. 28, 2019 (GLOBE NEWSWIRE) -- The "Kennedy s Disease R&D Pipeline Analysis Report, H2-2018" drug pipelines has been added to ResearchAndMarkets.com's offering.

Kennedy's Disease Drug Development Pipeline Study is the latest publication from this researcher with comprehensive information of Kennedy's Disease pipeline products.

The Kennedy's Disease pipeline guide presents complete overview of drugs currently being developed for Kennedy's Disease. The pipeline review provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials).

Drug development phase, current stage, mechanism of action, route of administration, orphan drug/ fast track/ other designations, drug class are provided for each of the Kennedy's Disease pipeline candidate.
Research and Development progress along with latest news related to each of the Kennedy's Disease pipeline candidates is included.

Major companies participating in therapeutic development of Kennedy's Disease are included in this pipeline report. Company wise pre clinical and clinical products along with details of drug originator, co developers/ licensors are provided.

Amid strong interest for cure of Kennedy's Disease from companies and institutes, the current research work serves as a reliable and comprehensive source of information of global Kennedy's Disease clinical and pre clinical products.

The report assists in identifying potential upcoming companies and drugs in Kennedy's Disease pipeline market along with progress of each drug. It also enables users to formulate effective strategies to stay ahead of competition.

Key Topics Covered:

I. Key Findings

1. Companies Investing in Kennedy's Disease Pipeline include
Number of Companies with Kennedy's Disease projects in pre clinical Development
Number of Companies with Kennedy's Disease projects in Clinical Development
Kennedy's Disease Pipeline Companies based in Americas
Kennedy's Disease Pipeline Companies based in Europe
Kennedy's Disease Pipeline Companies based in Asia Pacific
Kennedy's Disease Pipeline Companies based in Rest of the World

2. Pipeline Candidates include
Kennedy's Disease Pipeline Agents in pre clinical/ Discovery stage of Development
Kennedy's Disease Pipeline Agents in Clinical Development stage
Kennedy's Disease Pipeline Therapeutic Compounds received special status
Mechanism of Action of most pipeline Drugs
Small molecules among the Kennedy's Disease Pipeline agents

II. Insights into Kennedy's Disease Pipeline -

1. Disease Overview
Introduction to Kennedy's Disease
Symptoms and Causes of Kennedy's Disease
Treatment or Prevention Options for Kennedy's Disease
Other Details
2. Phase wise Pipeline Compounds
Kennedy's Disease Pipeline Pre Clinical/ Discovery stage Drugs
Kennedy's Disease Pipeline Phase 1 stage Drugs
Kennedy's Disease Pipeline Phase 2 stage Drugs
Kennedy's Disease Pipeline Phase 3 stage Drugs
Kennedy's Disease Pipeline Pre Registration stage Drugs
3. Company wise Kennedy's Disease Pipeline Compounds
4. Kennedy's Disease Pipeline by Mechanism of Action

III. Kennedy's Disease Pipeline Compound Details

Drug Details

1. Snapshot
Name of the Therapeutic Agent
Originator
Developing Company
Co Developer/ License Partner
Orphan Drug / Fast Track/ Designation
Development Phase
2. Drug Overview
3. Mechanism of Action
4. Current Status
5. Clinical Trial Details

IV. Kennedy's Disease Pipeline Company Briefs

V. Latest News and Developments in Global Kennedy's Disease Pipeline Market

VI. Appendix

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/724fwn/kennedys_disease?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs